Stockreport

The FDA's Upcoming Decision On Zynquista Is Key To Lexicon's Performance [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The FDA's Upcoming Decision On Zynquista Is Key To Lexicon's Performance Summary Xermelo continues to generate lackluster revenue for Lexicon, though prescriptions are g [Read more]